For Cancer, Our Goal Is To Create Novel Therapies That Arm Tumor-Associated Macrophages To Trigger Tumor Cell Killing.

We Have Developed Fully Humanized Antibodies (Patent Pending) That Trigger Macrophage-Mediated Antibody-Dependent Cellular Cytotoxicity (ADCC).